Individual Variation of Acetohexamide Reductase Activities in Liver Microsomes and Cytosol of Rats

スポンサーリンク

概要

• 論文の詳細を見る

• We examined individual variations in acetohexamide reductase activities in liver microsomes and cytosol of rats. Large differences among individuals were observed for acetohexamide reductase activity in liver microsomes of male Fischer-344 (Fischer), Sprague-Dawley (SD) and Wistar rats at 9 weeks of age, except in the Wistar-Imamichi (Wistar-IM) strain. These four strains of female rats did not exhibit any microsomal enzyme activity. Although acetohexamide reductase activities were fully detectable in liver cytosols from all the strains of male and female rats, there was neither strain-related difference nor considerable individual variation in the cytosolic enzyme activity. In liver microsomes of male Fischer rats at 4 weeks of age, acetohexamide reductase activity was not detectable. The microsomal enzyme activity in male Fischer rats markedly increased at 6 weeks of age to approach the levels at 9 and 12 weeks of age, with large individual variations.

• 公益社団法人日本薬学会の論文
• 1997-08-15

著者

• Mori Y

  Faculty Of Pharmaceutical Sciences Kumamoto University

• Mori Yukiko

  熊本大学 薬

• Imamura Y

  Kumamoto Univ. Kumamoto Jpn

• Imamura Yorishige

  Faculty Of Pharmaceutical Sciences Kumamoto University

• OTAGIRI MASAKI

  Faculty of Pharmaceutical Science, Kumamoto University

• MORI Yukiko

  Faculty of Pharmaceutical Sciences, Kumamoto University

• KOZONO Yuri

  Faculty of Pharmaceutical Sciences, Kumamoto University

• TAKADA Hidenori

  Faculty of Pharmaceutical Sciences, Kumamoto University

• Kozono Y

  Faculty Of Pharmaceutical Sciences Kumamoto University

• Takada Hidenori

  Faculty Of Pharmaceutical Sciences Kumamoto University

• Otagiri M

  Graduate School Of Pharmaceutical Sciences Kumamoto University

• Otagiri M

  Kumamoto Univ. Kumamoto Jpn

• Otagiri Masaki

  Faculty Of Pharmaceutical Science Kumamoto University

• Mori Y

  Dep. Of Biotechnology Fac. Of Engineering Toyama Prefectural Univ.

関連論文

• Fattiviracin A1, a Novel Antiviral Agent Produced by Streptomyces microflavus Strain No. 2445 II. Biological Properties
• Fattiviracin A1, a Novel Antiherpetic Agent Produced by Streptomyces microflavus Strain No. 2445 I. Taxonomy, Fermentation, Isolation, Physico-chemical Properties and Structure Elucidation
• Enzymatic Hydrolysis of the Horn and Hoof of Cow and Buffalo
• CD36 Is Not Involved in Scavenger Receptor-Mediated Endocytic Uptake of Glycolaldehyde- and Methylglyoxal-Modified Proteins by Liver Endothelial Cells
• Differential Pharmacokinetics of Acetohexamide in Male Wistar-Imamichi and Sprague-Dawley Rats : Role of Microsomal Carbonyl Reductase(Biopharmacy)
• Effect of Olmesartan on Oxidative Stress in Hemodialysis Patients
• Oxidation and Carboxy Methyl Lysine-Modification of Albumin : Possible Involvement in the Progression of Oxidative Stress in Hemodialysis Patients
• INCLUSION COMPLEXATIONS OF FLURBIPROFEN WITH β-CYCLODEXTRIN AND TRI-O-METHYL-β-CYCLODEXTRIN
• Interaction Mode of Dicumarol and Its Derivatives with Human Serum Albumin, α_1-Acid Glycoprotein and Asialo α_1-Acid Glycoprotein
• Catalytic Properties for Naphthoquinones and Partial Primary Structure of Rabbit Heart Acetohexamide Reductase.
• Catalytic Properties for Naphthoquinones and Partial Primary Structure of Rabbit Heart Acetohexamide Reductase
• Carbonyl Reductase Purified from Rabbit Liver Is Not the Product of a Carbonyl Reductase Gene (RCBR5 or RCBR6)Cloned from the Rabbit Liver cDNA Libray.
• Carbonyl Reductase Purified from Rabbit Liver Is Not the Product of a Carbonyl Reductase Gene (RCBR5 or RCBR6) Cloned from the Rabbit Liver cDNA Library
• Characterization of Acetohexamide Reductases Purified from Rabbit Liver, Kidney, and Heart: Structural Requirements for Substrates and Inhibitors
• Purifiation and Catalytic Properties of a Novel Acetohexamide-Reducing Enzyme from Rabbit Heart
• Stereoselective Reduction of Acetohexamide in Cytosol of Rabbit Liver
• Stability of a Cisplatin-Chondroitin Sulfate A Complex in Plasma and Kidney in Terms of Protein Binding
• The Physicochemical and Biopharmaceutical Properties of Fragmented Keratin as a New Drug Carrier
• Sex-Dependent Pharmacokinetics and in Vitro Reductive Metabolism of Acetohexamide in Wistar-Imamichi Rats
• Individual Variation of Acetohexamide Reductase Activities in Liver Microsomes and Cytosol of Rats
• Wistar-Imamichi Rats Exhibit a Strong Resistance to Cadmium Toxicity
• High-performance liquid chromatography with chemiluminescence detection of penbutolol and its hydroxylated metabolite in rat plasma
• Effects of Repeated Clarithromycin Administration on the Pharmacokinetic Properties of Pindolol in Rats
• α_1-Acid Glycoprotein Suppresses Rat Acute Inflammatory Paw Edema through the Inhibition of Neutrophils Activation and Prostaglandin E_2 Generation(Pharmacology)
• Effects of α_1-Acid Glycoprotein on Erythrocyte Deformability and Membrane Stabilization(Biopharmacy)
• Characterization of Ligand Binding Sites on the α_1-Acid Glycoprotein in Humans, Bovines and Dogs
• The Structural and Pharmacokinetic Properties of Oxidized Human Serum Albumin, Advanced Oxidation Protein Products (AOPP)
• Kinetic Studies of Covalent Binding between N-acetyl-L-cysteine and Human Serum Albumin Through a Mixed-disulfide Using an N-methylpyridinium Polymer-based Column
• EFFECT OF REPEATED ADMINISTRATION OF PYRIDINOLCARBAMATE ON THE RENAL EXCRETION OF SOME DRUGS IN RABBITS
• Characterization of a Binding Site of UCN-01,a Novel Anticancer Drug on α_1-Acid Glycoprotein
• Effects of Fatty Acids on Serum Binding between Furosemide and Valproic Acid
• Genetic Evidence of Resistance to Cadmium Toxicity in Wistar-Imamichi Rats
• Inclusion Complex of 3,9-Bis(N, N-dimethylcarbamoyloxy)-5H-benzofuro[3,2-c]quinoline-6-one (KCA-098) with Heptakis(2,6-di-O-methyl)-β-cyclodextrin : Interaction and Dissolution Properties
• Effect of Grinding with Hydroxypropyl Cellulose on the Dissolution and Particle Size of a Poorly Water-Soluble Drug
• Inhibitory Effects of Flavonoids on Rabbit Heart Carbonyl Reductase
• Enzymatic Synthesis of (-)- and (+)-Acetoxyhexamides and (-)- and (+)-Hydroxyhexamides
• Inhibition of Rabbit Heart Carbonyl Reductase by Fatty Acids
• Purification and Catalytic Properties of a Tetrameric Carbony1 Reductase from Rabbit heart
• STUDIES ON BEFUNOLOL REDUCTASE FROM RABBIT LIVER
• In Vivo and in Vitro Binding of (-)-Hydroxyhexamide, a Major Metabolite of Acetohexamide, to Rabbit Serum
• Metabolic Reduction of Acetohexamide in Rat Kidney : Sex Difference and Effect of Streptozotocin-Induced Diabetes
• SEX DIFFERENCE OF ACETOHEXAMIDE REDUCTION IN RAT LIVER
• EFFECTS OF VARIOUS FACTORS ON METABOLIC REDUCTION OF ACETOHEXAMIDE
• REDUCTION OF ACETOHEXAMIDE BY RABBIT HEART CYTOSOL
• Effect of Phenylbutazone on Serum Protein Binding and Pharmacokinetic Behavior of Sulfadimethoxine in Rabbits, Dogs and Rats
• SPECIES DIFFERENCE IN PROTEIN BINDING DISPLACEMENT OF SULFADIMETHOXINE
• EFFECT OF PHENYLBUTAZONE ON SERUM PROTEIN BINDING OF SULFADIMETHOXINE IN DIFFERENT ANIMAL SPECIES
• MODEL ANALYSIS OF INTERFACIAL TRANSFER AND ABSORPTION BEHAVIOR OF DRUG FOLLOWING DISSOLUTION FROM COMPRESSED TABLET : IN THE CASES OF SULFONAMIDES AND β-CYCLODEXTRIN COMPLEXES
• IMPROVEMENT OF ORAL BIOAVAILABILITY OF PREDNISOLONE BY β-CYCLODEXTRIN COMPLEXATION IN HUMANS
• ENHANCED ORAL BIOAVAILABILITY OF ANTIINFRAMMATORY DRUG FLURBIPROFEN IN RABBITS BY TRI-O-METHYL-β-CYCLODEXTRIN COMPLEXATION
• IMPROVEMENTS OF SOME PHARMACEUTICAL CHARACTERISTICS OF VARIOUS STEROIDAL DRUGS BY CYCLODEXTRIN COMPLEXATION
• REDUCTION IN THE LOCAL TISSUE TOXICITY OF CHLORPROMAZINE BY β-CYCLODEXTRIN COMPLEXATION
• Study of Interaction of Pranoprofen with Human Serum Albumin : Binding Properties of Enantiomers and Metabolite
• Receptor-Mediated Uptake of Human α1-Acid Glycoprotein into Liver Parenchymal Cells in Mice
• Construction of an Expression System for Human α_1-Acid Glycoprotein in E. coli : the Roles of Oligosaccharide Moieties in Structural and Functional Properties
• ENANTIOSELECTIVE ORAL BIOAVAILABILITY OF O-ISOVALERYL PROPRANOLOL AS A POTENTIAL PRODRUG OF PROPRANOLOL
• Interaction of Fluorescent Probe 7-Anilino-4-methylcoumarin-3-(p)-benzoic Acid with Egg Albumin
• ENHANCED BIOAVAILABILITY OF DIGOXIN BY γ-CYCLODEXTRIN COMPLEXATION
• REDUCTION IN THE LOCAL TOXICITY OF CHLORPROMACINE AND ITS PHOTOPRODUCTS BY CYCLODEXTRIN COMPLEXATION
• PROTECTIVE MECHANISM OF β-CYCLODEXIRIN FOR THE HEMOLYSIS INDUCED WITH PHENOTHIAZINE NEUROLEPTICS IN VITRO
• CYCLODEXTRIN-INDUCED HEMOLYSIS AND SHAPE CHANGES OF HUMAN ERYTHROCYTES IN VITRO
• PROTECTIVE EFFECTS OF CYCLODEXTRINS ON THE HEMOLYSIS INDUCED WITH TRANQUILIZING PHENOTHIAZINES
• PROTECTIVE EFFECTS OF CYCLODEXTRINS ON DRUG-INDUCED HEMOLYSIS IN VITRO
• Nanomolar Quantification and Identification of Various Nitrosothiols by High Performance Liquid Chromatography Coupled with Flow Reactors of Metals and Griess Reagent
• Enhanced Dissolution of Poorly Water-Soluble Drugs by Water-Soluble Gelatin
• THE ROLE OF SERUM PROTEIN BINDING IN THE INTESTINAL ABSORPTION OF DRUGS
• Opposite Effects of Metoclopramide and Propantheline on Intestinal Absorption of Imipramine in Rats
• INTERACTION OF WARFARIN WITH HUMAN SERUM ALBUMIN
• Effect of N-B Transition on the Microenvironment Surrounding ^Cys in Human Serum Albumin
• Activity coefficients of dimethyl-.BETA.-cyclodextrin in aqueous solutions.
• The structure of the cyclodextrin complex. XI. Crystal structure of hexakis-(2,3,6-tri-o-methyl)-.ALPHA.-cyclodextrin-p-iodoaniline monohydrate.
• The structure of the cyclodextrin complex. XIV. Crystal structure of hexakis(2,3,6-tri-O-methyl)-.ALPHA.-cyclodextrin-benzaldehyde (1:1) complex.
• The structure of the cyclodextrin complex. XVIII. Crystal structure of .BETA.-cyclodextrin-benzyl alcohol (1:1) complex pentahydrate.
• The structure of the cyclodextrin complex. XV. Crystal structure of hexakis(2,3,6-tri-O-methyl)-.ALPHA.-cyclodextrin-p-nitrophenol(1:1)complex monohydrate.
• The structure of the cyclodextrin complex. XIX Crystal structures of hexakis(2,3,6-tri-O-methyl)-.ALPHA.-cyclodextrin complexes with (S)- and (R)-mandelic acid. Chiral recognition through the induced-fit conformational change of the macrocyclic ring.
• The structure of the cyclodextrin complex. X. Crystal structure of .ALPHA.-cyclodextrin-benzaldehyde (1:1) complex hexahyderate.
• The structure of the cyclodextrin complex. XVI. Crystal structure of heptakis(2,3,6-tri-O-methyl)-.BETA.-cyclodextrin-p-iodophenol(1:1) complex tetrahydrate.

もっと見る 閉じる

スポンサーリンク